Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation
The DOI matches its Crossref record.
Abstract
It is important to establish an easy-to-use therapeutic protocol for the emergency medical care of patients involved in radiation accidents to reduce the radiation-related casualties. The present study aimed to establish an optimum therapeutic protocol using currently approved pharmaceutical drugs to increase the survival of victims exposed to lethal radiation. Different combinations of four drugs-recombinant human erythropoietin (EPO), granulocyte-colony stimulating factor (G-CSF), c-mpl receptor agonist romiplostim (RP) and nandrolone decanoate (ND)-were administered to mice within 2 h after exposure to a lethal 7 Gy dose of γ-irradiation. On day 30 after irradiation, the condition of the mice was analyzed using various hematological parameters, such as the number of peripheral blood cells, bone marrow cells, hematopoietic progenitor cells and the expression of cell surface antigens. Approximately 10% of the untreated irradiated control mice survived for 21 days, but all of the control mice died by day 30. The combined administration of G-CSF, EPO and RP for five days immediately after irradiation led to a complete survival of the irradiated mice until day 30. However, the treatment with G-CSF, EPO and RP with ND led to only 75% survival at day 30. The hematological analyses showed that the numbers of almost all of hematopoietic cells in the surviving mice treated with effective medications recovered to the levels of non-irradiated mice. The present findings show that the combination of G-CSF, EPO and RP may be a useful countermeasure for victims exposed to accidental lethal irradiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Singh, V. K., & Seed, T. M. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1969054 · Cited by 88
“Further, surviving, drug-treated mice showed complete hematological recovery (Hirouchi et al. 2015).”
BackgroundBunin, D. I., Bakke, J., Green, C. E., Javitz, H. S., Fielden, M., & Chang, P. Y. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1605465 · Cited by 60
“showed 100% 30-day survival in lethally irradiated mice after G-CSF, erythropoietin, and romiplostim were co-administered each for 5 days beginning 2 h post-irradiation compared with 63% survival when romiplostim was withheld from the dosing regimen (Hirouchi et al. 2015).”
MethodWong, K., Chang, P. Y., Fielden, M., Downey, A. M., Bunin, D., Bakke, J., Gahagen, J., Iyer, L., Doshi, S., Wierzbicki, W., et al. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1625488 · Cited by 57
Benderitter, M., Herrera-Reyes, E., Gigov, Y., Souleau, B., Huet, C., Trompier, F., Fagot, T., Grégoire, E., Malfuson, J. V., Konopacki-Potet, J., et al. (2021) · Radiation Research · doi:10.1667/rade-21-00169.1 · Cited by 15
Metadata
- Authors
- Hirouchi, T., Ito, K., Nakano, M., Monzen, S., Yoshino, H., Chiba, M., Hazawa, M., Nakano, A., Ishikawa, J., Yamaguchi, M., Tanaka, K., & Kashiwakura, I.
- Venue
- Current Pharmaceutical Biotechnology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2015-11-11
- Volume
- 17
- Issue
- 2
- Pages
- 190-199
- ISSN
- 1389-2010 (ISSN-L)
- OpenAlex
- W1144944919
- Cited by
- 27
- References
- 0
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation. https://app.cochat.ai/papers/10.2174/1389201016666150826125331
- The paper
- Hirouchi, T., Ito, K., Nakano, M., Monzen, S., Yoshino, H., Chiba, M., Hazawa, M., Nakano, A., Ishikawa, J., Yamaguchi, M., Tanaka, K., & Kashiwakura, I. (2015). Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation. Current Pharmaceutical Biotechnology. https://doi.org/10.2174/1389201016666150826125331
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.